Sahajanand Medical Technologies' initial public offering (IPO) entered its second day of bidding on October 16, 2026. The issue is commanding a grey market premium (GMP) of 12%, suggesting expectations of potential listing gains in the unofficial market. However, the GMP is subject to fluctuations and does not guarantee actual listing performance.
On Day 1, the IPO was subscribed 34% overall against the 97.50 lakh shares on offer. The retail individual investor (RII) category saw 40% subscription against the 47.50 lakh shares reserved for retail investors.